Endure Medical, Inc. Sustainability Profile
Endure Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in innovative healthcare solutions, focusing on advanced medical devices and patient monitoring systems. With a strong operational presence across North America and Europe, Endure Medical is dedicated to enhancing patient outcomes through cutting-edge technology. The company’s core offerings include state-of-the-art wearable devices and telehealth solutions, designed to provide real-time health data and improve chronic disease management. Endure Medical's commitment to quality and innovation has earned it recognition within the industry, positioning it as a trusted partner for healthcare providers. With a focus on patient-centric solutions, Endure Medical continues to drive advancements in the medical field, making significant strides towards improving healthcare delivery.
DitchCarbon Score
How does Endure Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Endure Medical, Inc.'s score of 28 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Endure Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is identified as a merged entity, inheriting performance data from its parent organisation, Alcon Inc. However, no specific emissions figures or reduction targets have been disclosed. As part of its climate commitments, Endure Medical, Inc. has not outlined any specific reduction initiatives or targets, including those aligned with the Science Based Targets initiative (SBTi). The lack of publicly available data on emissions and reduction strategies suggests that the company may still be in the early stages of developing its climate action framework. In the broader context of the industry, companies are increasingly expected to set ambitious targets for reducing carbon emissions across all scopes (Scope 1, 2, and 3) and to report transparently on their progress. Endure Medical, Inc. will need to establish clear commitments and measurable goals to align with these industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is Endure Medical, Inc.'s Industry?
How Carbon Intensive is Endure Medical, Inc.'s Location?
Endure Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Endure Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
